Skip to main content
. 2023 May 10;8:196. doi: 10.1038/s41392-023-01442-3

Table 3.

Target therapy related with metabolite sensing in cancers

Category Effect target Targeted medicine Targeted effect Ref./refs.
Glucose GLUT Phloretin Inhibitor 86
Fasentin 86
STF-31 86
WZB117 86
Ritonavir 86
Silybin 87
HK 2-DG Inhibitor 88,89
LN Inhibitor 90
Resveratrol Inhibitor 91
Astragalin Antagonist 92
Chrysin Antagonist 93
Genistein-27 Antagonist 94
Benserazide Inhibitor 95
PI3K/Akt Afuresertib Inhibitor 96
Uprosertib
Ipatasertib
mTORC1/2 PP242 Inhibitor 101
PI3K/mTOR NVP-BEZ235 Inhibitor 102
Fatty acid GPR109A MK1903 Antagonist 141
Acifran 142
5-ANA 143
GSK256073 144
Fatty acid β oxidation Etomuslim Antagonist 136
Peroxicillin
LDHA FX11 Inhibitor 150,152

N-hydroxy-2-carboxy-substituted

indole compounds

150,153
GPR43 4-CMTB Agonist 167170
AZ1729 167170
GPR84 Compound 33 Antagonist 174
GLPG1205 175
LY-237 Agonist 178
6-Octylaminouracil 179
GPR40 GW100 Antagonist 184
DC260126 185
GPR120 AH7614 Antagonist 187,188
GW9508 Agonist 190
TUG-891 192
Compound 39 193
GPR78 Anti-CTD GPR78 antibody Blocker 197
miR-936 Antagonist 198
HDAC Vorinostat Inhibitor 223225
Entinostat 226
Valproate 227
Romidepsin 228
CD44 CD44 mono-antibody Blocker 256
15-PGDH HDAC inhibitors Agonist 269
Nonsteroidal anti-inflammatory drugs
PPAR-γ agonists
FASN Cerulenin Inhibitor 278
ACSS2 MTB-9655 Inhibitor NCT04990739
ACC1 TOFA Inhibitor 285
ND-646 286,287
Amino acid mTOR Temsirolimus Inhibitor 322
eEF-2K 323
GPR109A Niacin Agonist 324
GPR56 Transglutaminase 2 Inhibitor 332
LGR5 Agonist 340
Glutamine ASCT2 Agonist 355
v-9302 Inhibitor 356
Leucine circFBXL5 Agonist 374
mTORC1 EP300 Agonist 378
BCAT BCAA Agonist 382,383
Serine PKM2 Agonist 388